The NHS Race and Health Observatory (RHO) has agreed to collaborate with the National Institute for Health and Care Excellence (NICE) to tackle persistent and systemic ethnic health inequalities. The ...

Linzagolix (Yselty) with hormonal add-back therapy will offer a new at-home treatment option for some women in England with ...

An OHE report analyses the rise in NICE’s optimised decisions from 2025 to 2024 and how they affect patient access, HTA ...

This partnership supports the strategic objectives of both organisations to tackle unwarranted health inequalities for Black, ...

The National Institute for Health and Care Excellence (NICE) has officially backed a AI tool for detecting skin cancer, marking a major milestone in the use of AI to free up specialist clinician’s ...

Endometriosis affects around 1.5 million women in the UK but, according to the National Institute for Health and Care ...

The National Institute for Health and Care Excellence (NICE) has recommended nivolumab (Opdivo) plus ipilimumab (Yervoy) for some people in England with advanced colorectal cancer. The treatment ...

As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have ...

The National Institute for Health and Care Excellence (Nice) said that the technology, which has been conditionally approved for the next three years, has the potential to reduce waiting times.

The U.K. National Institute for Health and Care Excellence (NICE) opened a late-stage assessment for drug-eluting stents (DES) with an eye toward costs, advising clinicians that they should implant ...

Endometriosis affects around 1.5 million women in the UK but, according to the National Institute for Health and Care Excellence (Nice), diagnosis typically takes nine years from when symptoms ...